Axsome Therapeutics
AXSM
AXSM
169 hedge funds and large institutions have $2.31B invested in Axsome Therapeutics in 2019 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 41 increasing their positions, 50 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
52% more funds holding
Funds holding: 111 → 169 (+58)
5.82% more ownership
Funds ownership: 54.97% → 60.79% (+5.8%)
18% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 50
Holders
169
Holding in Top 10
12
Calls
$251M
Puts
$126M
Top Buyers
| 1 | +$92.8M | |
| 2 | +$62M | |
| 3 | +$58.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$46.9M |
| 5 |
HM
HealthCor Management
New York
|
+$42.2M |
Top Sellers
| 1 | -$51.5M | |
| 2 | -$49.1M | |
| 3 | -$34.9M | |
| 4 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
-$31.2M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$30.7M |